TAM
SUPN icon

Tealwood Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Tealwood Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-75,447
Closed -$2.07M – 96
2019
Q3 		$2.07M Buy
75,447
+1,881
+3% +$55.7K 0.89% 68
2019
Q2 		$2.43M Buy
+73,566
New +$2.52M 0.99% 55

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Tealwood Asset Management's SUPN Position: Q4 2019 in Review

Tealwood Asset Management sold out of Supernus Pharmaceuticals (SUPN) in Q4 2019, closing a stake of 75,447 shares — an estimated $2.07M sold.

Tealwood Asset Management first reported a position in SUPN in Q2 2019 and held it in 2 quarters. The position peaked at $2.43M in Q2 2019. 235 funds tracked by Wall St. Rank hold SUPN as of Q4 2019.

  • Tealwood Asset Management reported no remaining Supernus Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Tealwood Asset Management sold 75,447 Supernus Pharmaceuticals shares in Q4 2019, an estimated $2.07M.
  • Tealwood Asset Management first reported a position in Supernus Pharmaceuticals in Q2 2019 and held it in 2 quarters.
  • Tealwood Asset Management's Supernus Pharmaceuticals position peaked at $2.43M in Q2 2019.
  • 235 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2019.

Based on Tealwood Asset Management's 13F filing for Q4 2019, filed 16 Jan 2020.